• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

囊性纤维化及CFTR相关疾病的顿挫型

Cystic fibrosis and formes frustes of CFTR-related disease.

作者信息

Southern Kevin W

机构信息

Royal Liverpool Children's Hospital, Institute of Child Health, University of Liverpool, Liverpool, UK.

出版信息

Respiration. 2007;74(3):241-51. doi: 10.1159/000102068.

DOI:10.1159/000102068
PMID:17534127
Abstract

Cystic fibrosis (CF) is the commonest genetic cause of bronchiectasis in the Caucasian population. Since identification of the putative gene in 1989, the molecular basis of the condition has become clearer with characterisation of the unique pathophysiology. The small airways are the primary site of lung disease, with an intense but localised inflammatory picture, dominated by neutrophils. The clinical heterogeneity is explained to some degree by the distinct molecular consequences of the many mutations that have been recognised to affect the CF transmembrane conductance regulator (CFTR) gene; however other genes appear to modify the phenotype as well as environmental exposure. It has become increasingly apparent that certain conditions may result from CFTR dysfunction without fulfilling diagnostic criteria for CF. In some cases this may result in single organ disease for which the term CF (or CFTR)-related disease has been advocated. Congenital bilateral absence of the vas deferens is the most clearly characterised of these. In other cases where a mild CF phenotype is apparent, atypical CF is probably a better term. It remains unclear whether carrier status predisposes to certain conditions such as chronic rhinosinusitis or pancreatitis.

摘要

囊性纤维化(CF)是白种人群中支气管扩张最常见的遗传病因。自1989年确定可能的致病基因以来,随着独特病理生理学特征的描述,该病的分子基础已变得更加清晰。小气道是肺部疾病的主要部位,呈现强烈但局限的炎症表现,以中性粒细胞为主。临床异质性在一定程度上可由已确认影响CF跨膜传导调节因子(CFTR)基因的众多突变所产生的不同分子后果来解释;然而,其他基因以及环境暴露似乎也会改变表型。越来越明显的是,某些情况可能由CFTR功能障碍导致,但不符合CF的诊断标准。在某些情况下,这可能导致单器官疾病,对此有人主张使用术语CF(或CFTR)相关疾病。先天性双侧输精管缺如是其中特征最明确的一种。在其他出现轻度CF表型的情况下,非典型CF可能是一个更好的术语。目前尚不清楚携带者状态是否易患某些疾病,如慢性鼻窦炎或胰腺炎。

相似文献

1
Cystic fibrosis and formes frustes of CFTR-related disease.囊性纤维化及CFTR相关疾病的顿挫型
Respiration. 2007;74(3):241-51. doi: 10.1159/000102068.
2
Assessing the Disease-Liability of Mutations in CFTR.评估 CFTR 突变的疾病致病变异。
Cold Spring Harb Perspect Med. 2012 Dec 1;2(12):a009480. doi: 10.1101/cshperspect.a009480.
3
Genetic diagnosis in practice: From cystic fibrosis to CFTR-related disorders.临床中的基因诊断:从囊性纤维化到CFTR相关疾病
Arch Pediatr. 2020 Feb;27 Suppl 1:eS25-eS29. doi: 10.1016/S0929-693X(20)30047-6.
4
Mutations in the cystic fibrosis gene in men with congenital bilateral absence of the vas deferens.先天性双侧输精管缺如男性囊性纤维化基因的突变
Mol Hum Reprod. 1996 Sep;2(9):669-77. doi: 10.1093/molehr/2.9.669.
5
Genotype and phenotype in cystic fibrosis.囊性纤维化中的基因型与表型。
Respiration. 2000;67(2):117-33. doi: 10.1159/000029497.
6
Heterogeneous spectrum of mutations in CFTR gene from Indian patients with congenital absence of the vas deferens and their association with cystic fibrosis genetic modifiers.来自印度先天性输精管缺如患者的CFTR基因突变异质性谱及其与囊性纤维化遗传修饰因子的关联。
Mol Hum Reprod. 2014 Sep;20(9):827-35. doi: 10.1093/molehr/gau047. Epub 2014 Jun 23.
7
Effects of cystic fibrosis and congenital bilateral absence of the vas deferens-associated mutations on cystic fibrosis transmembrane conductance regulator-mediated regulation of separate channels.囊性纤维化及先天性双侧输精管缺如相关突变对囊性纤维化跨膜传导调节因子介导的不同通道调节的影响
Am J Hum Genet. 2000 May;66(5):1485-95. doi: 10.1086/302893. Epub 2000 Apr 4.
8
Genotypes and phenotypes in cystic fibrosis and cystic fibrosis transmembrane regulator-related disorders.囊性纤维化及囊性纤维化跨膜传导调节因子相关疾病中的基因型与表型
Semin Respir Crit Care Med. 2015 Apr;36(2):180-93. doi: 10.1055/s-0035-1547318. Epub 2015 Mar 31.
9
Cystic fibrosis transmembrane conductance regulator channel dysfunction in non-cystic fibrosis bronchiectasis.非囊性纤维化支气管扩张症中囊性纤维化跨膜电导调节子通道功能障碍。
Am J Respir Crit Care Med. 2010 May 15;181(10):1078-84. doi: 10.1164/rccm.200909-1434OC. Epub 2010 Feb 18.
10
[Cystic fibrosis transmembrane conductance regulator (CFTR) gene: mutations and clinical phenotypes].[囊性纤维化跨膜传导调节因子(CFTR)基因:突变与临床表型]
Ugeskr Laeger. 2003 Feb 24;165(9):912-6.

引用本文的文献

1
Cystic Fibrosis and Hemochromatosis Carriers May Be Prone to Glucagon-like Peptide-1 Agonist Pancreatitis: 3 Cases.囊性纤维化和血色素沉着症携带者可能易患胰高血糖素样肽-1激动剂所致胰腺炎:3例报告
JCEM Case Rep. 2025 May 15;3(7):luaf104. doi: 10.1210/jcemcr/luaf104. eCollection 2025 Jul.
2
Diagnosing Cystic Fibrosis in the 21st Century-A Complex and Challenging Task.21世纪诊断囊性纤维化——一项复杂且具有挑战性的任务。
Diagnostics (Basel). 2024 Apr 3;14(7):763. doi: 10.3390/diagnostics14070763.
3
Corrector therapies (with or without potentiators) for people with cystic fibrosis with class II CFTR gene variants (most commonly F508del).
针对携带 II 类 CFTR 基因突变(最常见的是 F508del)的囊性纤维化患者的校正治疗(有或没有增效剂)。
Cochrane Database Syst Rev. 2023 Nov 20;11(11):CD010966. doi: 10.1002/14651858.CD010966.pub4.
4
Corrector therapies (with or without potentiators) for people with cystic fibrosis with class II CFTR gene variants (most commonly F508del).针对具有 II 类 CFTR 基因突变(最常见的是 F508del)的囊性纤维化患者的校正治疗(含或不含增效剂)。
Cochrane Database Syst Rev. 2020 Dec 17;12(12):CD010966. doi: 10.1002/14651858.CD010966.pub3.
5
Potentiators (specific therapies for class III and IV mutations) for cystic fibrosis.囊性纤维化的增效剂(针对III类和IV类突变的特定疗法)。
Cochrane Database Syst Rev. 2019 Jan 7;1(1):CD009841. doi: 10.1002/14651858.CD009841.pub3.
6
Correctors (specific therapies for class II CFTR mutations) for cystic fibrosis.囊性纤维化的校正剂(针对II类CFTR突变的特异性疗法)
Cochrane Database Syst Rev. 2018 Aug 2;8(8):CD010966. doi: 10.1002/14651858.CD010966.pub2.
7
Screening for cystic fibrosis in New York State: considerations for algorithm improvements.纽约州囊性纤维化的筛查:算法改进的考量因素
Eur J Pediatr. 2016 Feb;175(2):181-93. doi: 10.1007/s00431-015-2616-3. Epub 2015 Aug 21.
8
Topical nasal steroids for treating nasal polyposis in people with cystic fibrosis.局部用鼻用类固醇治疗囊性纤维化患者的鼻息肉病。
Cochrane Database Syst Rev. 2015 Jun 22;2015(6):CD008253. doi: 10.1002/14651858.CD008253.pub4.
9
Atypical cystic fibrosis and CFTR-related diseases.非典型囊性纤维化及与囊性纤维化跨膜传导调节因子相关的疾病
Clin Rev Allergy Immunol. 2008 Dec;35(3):116-23. doi: 10.1007/s12016-008-8083-0.